ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $23,000 | +15.0% | 692 | +19.3% | 0.00% | 0.0% |
Q2 2022 | $20,000 | +42.9% | 580 | +87.7% | 0.00% | 0.0% |
Q1 2022 | $14,000 | -94.0% | 309 | -91.8% | 0.00% | -91.7% |
Q3 2021 | $235,000 | -47.1% | 3,760 | -29.9% | 0.01% | -42.9% |
Q2 2021 | $444,000 | +59.7% | 5,366 | +27.9% | 0.02% | +50.0% |
Q1 2021 | $278,000 | +6850.0% | 4,194 | +9017.4% | 0.01% | +1300.0% |
Q4 2020 | $4,000 | -97.1% | 46 | -98.6% | 0.00% | -88.9% |
Q3 2020 | $140,000 | +15.7% | 3,242 | +15.1% | 0.01% | +12.5% |
Q2 2020 | $121,000 | +152.1% | 2,816 | +61.4% | 0.01% | +100.0% |
Q1 2020 | $48,000 | -74.7% | 1,745 | -41.9% | 0.00% | -66.7% |
Q4 2019 | $190,000 | +21.0% | 3,001 | -46.6% | 0.01% | +20.0% |
Q3 2019 | $157,000 | -31.1% | 5,620 | -34.9% | 0.01% | -37.5% |
Q2 2019 | $228,000 | +142.6% | 8,631 | +69.4% | 0.02% | +128.6% |
Q1 2019 | $94,000 | +8.0% | 5,095 | -26.2% | 0.01% | -12.5% |
Q4 2018 | $87,000 | -32.6% | 6,908 | +1.9% | 0.01% | -20.0% |
Q3 2018 | $129,000 | +2050.0% | 6,776 | +414.1% | 0.01% | +900.0% |
Q3 2017 | $6,000 | +200.0% | 1,318 | -2.0% | 0.00% | – |
Q2 2017 | $2,000 | 0.0% | 1,345 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | -33.3% | 1,345 | -33.3% | 0.00% | – |
Q4 2016 | $3,000 | – | 2,015 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |